Compare Canadian Natural Resources Ltd. (CNQ) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Natural Resources Ltd. vs BIO-TECHNE Corp — how do they compare? Canadian Natural Resources Ltd. trades at $48.06 (market cap $97.27B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Canadian Natural Resources Ltd. is far larger — about 8.7× BIO-TECHNE Corp's market cap, and Canadian Natural Resources Ltd. pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| CNQ | TECH | |
|---|---|---|
Market Cap | $97.27B | $11.24B |
Sector | Energy | Health |
52-Week High | $50.55 | $72.29 |
52-Week Low | $29.31 | $43.31 |
Enterprise Value | $107.68B | $11.32B |
Dividend Yield | 3.76% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canadian Natural Resources (CNQ) trades at $45.51, up 0.13% with strong technical momentum and bullish moving average signals. The company delivered impressive Q2 2026 results with EPS of $1.53 beating estimates by 7%, driven by record production and operational efficiency. Financials show robust profitability with 22.87% net margin and 26.69% ROE, while valuation remains attractive at 11.35 P/E. Recent news highlights dividend consistency and institutional accumulation.
CNQ presents a compelling investment case with strong fundamentals, consistent earnings beats, and shareholder returns through dividends. Key opportunities include production growth guidance increases and favorable oil pricing exposure. Risks include commodity price volatility and rising capital expenditures. Analyst consensus remains strongly bullish with 75% buy ratings supporting upside potential.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
